Wells Fargo analyst Stan Berenshteyn raised the firm’s price target on Doximity (DOCS) to $55 from $43 and keeps an Equal Weight rating on the shares. The firm says it doubts anyone was surprised by the Q3 beat and raise, but management cautioned on extrapolating glide path into FY26, noting historically the norm has been “2-turns performance vs the market,” while 2025 is trending to 3-turns, with market growth estimate at about 7%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
